Skip to content
GLP-1 Scorecard
Menu
Site position #503

VevaRX

Edited by Dana WhitfieldUpdated

VevaRX publishes four prices for semaglutide on one page, two of which belong to tirzepatide, and gets its own per-month arithmetic wrong in the process.

Visit VevaRX ↗We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$189/mo (the same page also prints $167 a month and $467 for three months)
Tirzepatide
$467 per three months, auto-renewing (about $155.67 a month; no monthly option is offered)
Coverage
36 states
Brand-name
Not confirmed

Weigh VevaRX against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value35/100
Dose & formulation64/100
Clinical oversight66/100
Labs & monitoring62/100
Fulfillment75/100
Contract terms20/100

Strengths

  • Publishes an exact 36-state list by name rather than a nationwide claim it then hedges
  • States what the three-month figure covers — medication, supplies and the provider visit — and includes free two- to three-day shipping
  • Unlimited physician access and a 24/7 care team are described as inside the program price
  • Prices its peptide products openly beside the GLP-1 lines

Where it loses points

  • Tirzepatide has no monthly option: it is sold as $467 for three months on a quarterly auto-renewal with a three-month minimum
  • The tirzepatide page's own arithmetic is wrong — it calls $467 equivalent to $149 a month when the figure is $155.67, which the semaglutide page states correctly
  • The semaglutide page carries four prices, two of which belong to tirzepatide
  • Follow-up consultations are priced separately at $299 and $399, which the program pages do not mention
  • NAD+ is priced three different ways on one page, at $399, $447 and $267
  • Another company's domain appears in VevaRX's own Terms, in the transaction currency clause
  • The contact page FAQ is a different product's copy and gives dosing instructions for a powdered drink under the question of how to take semaglutide or tirzepatide
  • Two opposite return policies are live, and no pharmacy, compounding class, clinician or medical group is named anywhere

Bottom line — Grade C

Best for: Readers in its 36 states who want a three-month program and will confirm every figure with support before paying.

Site position #503 of 542. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest VevaRX — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect VevaRX's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on VevaRX's site. Not medical advice; see our disclosure.

← Back to the scorecard